XJPX
4326
Market cap437mUSD
Jul 10, Last price
1,878.00JPY
1D
0.97%
1Q
12.52%
Jan 2017
89.79%
IPO
369.21%
Name
Intage Holdings Inc
Chart & Performance
P/E
20.47
P/S
1.09
EPS
91.73
Div Yield, %
2.50%
Shrs. gr., 5y
-1.00%
Rev. gr., 5y
3.13%
Revenues
65.57b
+3.62%
Net income
3.51b
+42.67%
CFO
6.43b
+226.03%
Dividend
Jun 29, 202624 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
INTAGE HOLDINGS Inc., established in 1960 and headquartered in Tokyo, Japan, is a prominent provider of market research and data solutions, operating globally. The company organizes its services across three main divisions: Marketing Support for Consumer Goods & Services, Marketing Support for Healthcare, and Business Intelligence. For its consumer goods and services clients, which include manufacturers, advertisers, government bodies, and IT firms, INTAGE offers customized and panel-based research to bolster their marketing strategies. Within the healthcare sector, the company specializes in analyzing prescription data, conducting extensive market surveys for both over-the-counter and prescription drugs for pharmaceutical companies, and also serves as a Contract Research Organization (CRO). The Business Intelligence segment provides a broad array of technology-driven and operational services, such as system development and management, business process outsourcing (BPO), data center operations, advanced data modeling, and data utilization consulting. Additionally, it offers enterprise solutions, specialized research, and comprehensive IT infrastructure support, including architecture, implementation, ongoing operations, and auditing, for diverse industries like pharmaceuticals, manufacturing, retail, travel, and advertising. The company rebranded from INTAGE Inc. to INTAGE HOLDINGS Inc. in October 2013.
IPO date
Nov 29, 2001
Employees
3,135
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||